Filer Snapshot

Ian McDonald

CIK 0002005665. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

1

Latest filing

02 Jul 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13D/G stake for DRUG. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

DRUG

04 Nov 2024 · 14% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Schedule 13D/G

SCHEDULE 13D/A filed on 02 Jul 2026 for CIK 0002005665.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

DRUG
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
Park Towers B804, Difc, Dubai, United Arab Emirates, --

Filer intelligence

What SEC filings say about Ian McDonald

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • 1 recent 13D/G stake row found; top row is DRUG at 14% ownership.
  • Forms 3/4/5 show insider context for ABP.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes 1 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

13D/G large-stake context

DRUG

04 Nov 2024 · COMMON STOCK, WITHOUT PAR VALUE

14%

Forms 3/4/5 insider context

ABP

13 Nov 2024

Latest update

What changed recently for Ian McDonald

New filing available

Latest Schedule 13D/G period: 04 Nov 2024. Open the source-backed page to inspect the fresh filing or facts context.

Update date

02 Jul 2026

Page type

Filer profile

Latest period

04 Nov 2024

Schedule 13D/G context is visible from filings filed on 02 Jul 2026.

SEC filing record

CIK 0002005665 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
1
First seen
02 Jul 2026
Latest filing
02 Jul 2026
Entity
Individual

Observed form types

SCHEDULE 13D/A

Latest Filings

Showing the latest 1 of 1 SEC filings for Ian McDonald.

SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
02 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .